» Articles » PMID: 37035729

-related Muscular Dystrophy: Identification of Variants in Alternative Genes and Personalized Clinical Translation

Abstract

Laminopathies are caused by rare alterations in , leading to a wide clinical spectrum. Though muscular dystrophy begins at early ages, disease progression is different in each patient. We investigated variability in laminopathy phenotypes by performing a targeted genetic analysis of patients diagnosed with -related muscular dystrophy to identify rare variants in alternative genes, thereby explaining phenotypic differences. We analyzed 105 genes associated with muscular diseases by targeted sequencing in 26 pediatric patients of different countries, diagnosed with any -related muscular dystrophy. Family members were also clinically assessed and genetically analyzed. All patients carried a pathogenic rare variant in . Clinical diagnoses included Emery-Dreifuss muscular dystrophy (EDMD, 13 patients), -related congenital muscular dystrophy (L-CMD, 11 patients), and limb-girdle muscular dystrophy 1B (LGMD1B, 2 patients). In 9 patients, 10 additional rare genetic variants were identified in 8 genes other than . Genotype-phenotype correlation showed additional deleterious rare variants in five of the nine patients (3 L-CMD and 2 EDMD) with severe phenotypes. Analysis f known genes related to muscular diseases in close correlation with personalized clinical assessments may help identify additional rare variants of potentially associated with early onset or most severe disease progression.

Citing Articles

Congenital LMNA-Related Muscular Dystrophy in Paediatrics: Cardiac Management in Monozygotic Twins.

Martinez Oloron P, Alegria I, Cesar S, Del Olmo B, Martinez-Barrios E, Carrera-Garcia L Int J Mol Sci. 2024; 25(11).

PMID: 38892025 PMC: 11171958. DOI: 10.3390/ijms25115836.


Creatine and L-carnitine attenuate muscular laminopathy in the LMNA mutation transgenic zebrafish.

Pan S, Wang H, Hsiao H, Hsu P, Tseng Y, Liang W Sci Rep. 2024; 14(1):12826.

PMID: 38834813 PMC: 11150447. DOI: 10.1038/s41598-024-63711-7.


The Influence of a Genetic Variant in on -Associated Skeletal Muscle Disease.

Mohar N, Cox E, Adelizzi E, Moore S, Mathews K, Darbro B Int J Mol Sci. 2024; 25(9).

PMID: 38732148 PMC: 11084688. DOI: 10.3390/ijms25094930.

References
1.
Bennett R, Campbell T, Eslick A, Pudipeddi A, Hing A, Yeates L . Ventricular Tachycardia in a Patient With Dilated Cardiomyopathy Caused by a Novel Mutation of Lamin A/C Gene: Insights From Features on Electroanatomic Mapping, Catheter Ablation and Tissue Pathology. Heart Lung Circ. 2020; 30(2):310-317. DOI: 10.1016/j.hlc.2020.08.024. View

2.
Jedrzejowska M, Potulska-Chromik A, Gos M, Gambin T, Debek E, Rosiak E . Floppy infant syndrome as a first manifestation of LMNA-related congenital muscular dystrophy. Eur J Paediatr Neurol. 2021; 32:115-121. DOI: 10.1016/j.ejpn.2021.04.005. View

3.
Liu X, Wang Z, Jin W, Lv H, Zhang W, Que C . Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G > C as the most common mutation. BMC Med Genet. 2014; 15:141. PMC: 4411720. DOI: 10.1186/s12881-014-0141-2. View

4.
McCready M, Carson N, Chakraborty P, Clarke J, Callahan J, Skomorowski M . Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II. Mol Genet Metab. 2007; 92(4):325-35. DOI: 10.1016/j.ymgme.2007.07.006. View

5.
Bonne G, Ben Yaou R, Beroud C, Boriani G, Brown S, de Visser M . 108th ENMC International Workshop, 3rd Workshop of the MYO-CLUSTER project: EUROMEN, 7th International Emery-Dreifuss Muscular Dystrophy (EDMD) Workshop, 13-15 September 2002, Naarden, The Netherlands. Neuromuscul Disord. 2003; 13(6):508-15. DOI: 10.1016/s0960-8966(03)00063-4. View